Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder

被引:130
作者
Hungerhuber, Edwin
Stepp, Herbert
Kriegmair, Martin
Stief, Christian
Hofstetter, Alfons
Hartmann, Arndt
Knuechel, Ruth
Karl, Alexander
Tritschler, Stefan
Zaak, Dirk
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Urol, D-81366 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Laser Res Lab, D-81366 Munich, Germany
[3] Urol Clin Planegg, Dept Urol, Munich, Germany
[4] Univ Regensburg, Dept Pathol, D-8400 Regensburg, Germany
[5] RWTH Aachen Univ Technol, Inst Pathol, Aachen, Germany
关键词
D O I
10.1016/j.urology.2006.10.015
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES Photodynamic diagnosis (PDD) using 5-aminolevulinic acid has proved to be a procedure with an outstanding sensitivity for the detection of transitional cell carcinoma of the bladder, in particular in the detection of flat urothelial lesions. We report on our clinical results with 875 patients (1713 PDD procedures) between March 1995 and March 2002. METHODS A total of 1713 PDD procedures were done in 875 patients. Fluorescence imaging was performed 2 to 3 hours after instillation of 50 mL of a 3% solution of 5-aminolevulinic acid into the bladder by an incoherent light source. In total, specimens from 4630 lesions (2.7 tesions/PDD) were taken. RESULTS In 34.8% of all biopsies, the histologic finding was malignant; 23.7% of these biopsies had been taken only because of positive fluorescence. In 28.5.% of the positive biopsies, flat lesions had been identified. Also, 43.4% of carcinoma in situ and 30.7% of dysplasia II degrees were detected only by positive fluorescence. Of all tumor lesions, 92.0% were detected by PDD compared with 76.3% detected by white tight endoscopy. CONCLUSIONS PDD has proved to be an effective detection device for superficial bladder cancer.
引用
收藏
页码:260 / 264
页数:5
相关论文
共 33 条
  • [1] NON-INVASIVE PAPILLARY CARCINOMA OF BLADDER ASSOCIATED WITH CARCINOMA INSITU
    ALTHAUSEN, AF
    PROUT, GR
    DALY, JJ
    [J]. JOURNAL OF UROLOGY, 1976, 116 (05) : 575 - 580
  • [2] Bastacky S, 1999, CANCER CYTOPATHOL, V87, P118, DOI 10.1002/(SICI)1097-0142(19990625)87:3<118::AID-CNCR4>3.0.CO
  • [3] 2-N
  • [4] Natural history of urothelial dysplasia of the bladder
    Cheng, L
    Cheville, JC
    Neumann, RM
    Bostwick, DG
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (04) : 443 - 447
  • [5] Cheng L, 2000, CANCER, V88, P625, DOI 10.1002/(SICI)1097-0142(20000201)88:3<625::AID-CNCR20>3.3.CO
  • [6] 2-1
  • [7] Epidemiology and etiology of premalignant and malignant urothelial changes
    Cohen, SM
    Shirai, T
    Steineck, G
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 : 105 - 115
  • [8] Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer:: Improvement in diagnostic sensitivity
    De Dominicis, C
    Liberti, M
    Perugia, G
    De Nunzio, C
    Sciobica, F
    Zuccalà, A
    Sarkozy, A
    Iori, F
    [J]. UROLOGY, 2001, 57 (06) : 1059 - 1062
  • [9] Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid
    Filbeck, T
    Roessler, W
    Knuechel, R
    Straub, M
    Kiel, HJ
    Wieland, WF
    [J]. JOURNAL OF ENDOUROLOGY, 1999, 13 (02) : 117 - 121
  • [10] 5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors
    Filbeck, T
    Roessler, W
    Knuechel, R
    Straub, M
    Kiel, HJ
    Wieland, WF
    [J]. UROLOGY, 1999, 53 (01) : 77 - 81